ITERUM THERAPEUTICS PLC

Insiders Iterum Therapeutics plc

Equities

ITRM

IE000TTOOBX0

Market Closed - Nasdaq Other stock markets 21:30:01 09/05/2024 BST			5-day change	1st Jan Change
1.61 ^USD	+0.62%		+1.90%	-18.27%

04-29	Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem	CI
03-28	Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Iterum Therapeutics plc Announces the Resignation of Mark Chin as Director, Effective December 31, 2023	12-29	CI
Iterum Therapeutics plc Appoints Sailaja Puttagunta as Chief Medical Officer	13/12/21	CI
Iterum Therapeutics plc Announces Resignation of Shahzad Malik from the Board of Directors	14/06/21	CI
Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors	16/03/21	CI
Iterum Therapeutics plc Announces Executive Changes	23/12/20	CI
Iterum Therapeutics plc Announces Resignation of James I. Healy as Member of the Board of Directors	14/02/20	CI
Iterum Therapeutics plc Announces Paul R. Edick Term Will Expire At the AGM	25/04/19	CI
Iterum Therapeutics Limited Appoints Jeff Schaffnit as Chief Commercial Officer	20/02/18	CI
Iterum Therapeutics Ltd. Announces Board Appointments	24/03/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer